Profil bibliographique

Johnna Perdrizet

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

76Publications signalées

675Citations signalées

4Affiliations récentes

Institutions déclarées

Pfizer (United States)TransCanada (Canada)Evidence (Italy)Pfizer (Canada)

Domaines associés

Pneumonia and Respiratory InfectionsRespiratory viral infections researchAdvanced Causal Inference TechniquesChild and Adolescent HealthVaccine Coverage and Hesitancy

Publications récentes

Accès ouvert 2025 articleOpenAlex

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population

S. Fiévez, An Ta, L. Bellier, Emmanuelle Blanc et autres

2 citationsInfectious Diseases and Therapy

Accès ouvert 2025 articleOpenAlex

Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany

Johnna Perdrizet, Dominik Schröder, Felicitas Kühne, J. Schiffner‐Rohe et autres

0 citationsJournal of Medical Economics

Accès ouvert 2025 articleOpenAlex

Cost-effectiveness analysis of 20-valent anti-pneumococcal vaccination in the Spanish pediatric population

F. Garcia, Federico Martinón‐Torres, Valentí Pineda, Alejandra López-Ibáñez de Aldecoa et autres

3 citationsExpert Review of Pharmacoeconomics & Outcomes Research

Accès ouvert 2025 articleOpenAlex

Real-World Impact of Pneumococcal Conjugate Vaccines on Vaccine Serotypes and Potential Cross-Reacting Non-Vaccine Serotypes

Kevin Apodaca, Lindsay R. Grant, Johnna Perdrizet, Derek Daigle et autres

2 citationsVaccines

Accès ouvert 2025 articleOpenAlex

Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine (PCV20) to prevent pneumococcal disease in the Greek pediatric population

C. Tzanetakos, Ioanna Kokkinaki, Myrto Barmpouni, Vasiliki Kossyvaki et autres

3 citationsExpert Review of Vaccines

Accès ouvert 2025 articleOpenAlex

Impact of delaying PCV20 implementation in France’s pediatric national immunization program: A population-based Markov model

Johnna Perdrizet, Emmanuelle Blanc, Maud Beillat, Ayman Sabra et autres

3 citationsInfectious Diseases Now

Accès ouvert 2025 articleOpenAlex

Cost-effectiveness analysis of implementing 20-valent pneumococcal conjugate vaccine into the Romanian pediatric national immunization program

An Ta, Elizabeth Vinand, Veronica Purdel, Ana Maria Zdrafcovici et autres

2 citationsJournal of Medical Economics

Accès ouvert 2025 articleOpenAlex

Indirect Comparison of PCV20 Immunogenicity with PCV10 in Pediatric 3 + 1 and 2 + 1 Schedules

Eileen M. Dunne, Valda A. Struwig, Johnna Perdrizet, Noor Tamimi et autres

3 citationsInfectious Diseases and Therapy

Accès ouvert 2025 preprintOpenAlex

Evaluating the Impact of Population-Based and Cohort-Based Models in Cost-Effectiveness Analysis: A Case Study of Pneumococcal Conjugate Vaccines in Infants in Germany

Johnna Perdrizet, Dominik Schröder, Felicitas Kühne, J. Schiffner‐Rohe et autres

0 citationsmedRxiv

Accès ouvert 2025 articleOpenAlex

Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme

Esra Şükran Çakar, An Ta, Elizabeth Vinand, Angela Waterval-Overbeek et autres

6 citationsInfectious Diseases and Therapy

Accès ouvert 2025 articleOpenAlex

Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit

Johnna Perdrizet, An Ta, Liping Huang, Warisa Wannaadisai et autres

6 citationsInfectious Diseases and Therapy

Accès ouvert 2025 articleOpenAlex

P-628. Real-world impact of pneumococcal conjugate vaccines on vaccine serotypes and cross-reacting non-vaccine serotypes

Kevin Apodaca, Lindsay R. Grant, Johnna Perdrizet, Derek Daigle et autres

0 citationsOpen Forum Infectious Diseases

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.